Investing Profile

Adam Koppel

InvestorVC

Managing Director at Bain Capital Life Sciences

baincapital.comMassachusetts
Photo of Adam Koppel, Managing Director at Bain Capital Life Sciences

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Bain Capital Life Sciences Managing Director
$100K - $5.0M
$1.5M
6
CompanyStageDateRound SizeTotal Raised
Synapticure
Seed RoundFeb 2022$6M
$16M
Co-investors: Ronald Conway Sr. (SV Angel), Jeff Huber (Triatomic Capital), Joe Kraus (GV), David Hodgson (General Atlantic), Ben Silbermann
ViaCyte
Series DNov 2018$80M
$140M
Co-investors: Asish Xavier (Johnson & Johnson Innovation)
Cerevel Therapeutics
Private Equity RoundOct 2018$350M
$350M
Co-investors: Chris Gordon (Bain Capital)
Aptinyx
Series BDec 2017$70M
$140M
Co-investors: Liam Ratcliffe (Access Biotechnology)
InflaRx
Series DOct 2017$55M
$55M
PTC Therapeutics
Private Equity RoundMar 2013$60M
$60M
Co-investors: Rich Aldrich (Longwood Fund)